Afs Financial Group, LLC Eli Lilly & CO Transaction History

Afs Financial Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	SELL	$434.7 - $599.3 $30,863 - $42,550	-71 Reduced 7.94%	823 $442 Million
Q2 2023 Jul 17, 2023	SELL	$350.74 - $468.98 $19,641 - $26,262	-56 Reduced 5.89%	894 $419 Million
Q1 2023 Apr 20, 2023	BUY	$310.63 - $364.82 $46,594 - $54,723	150 Added 18.75%	950 $326 Million
Q4 2022 Jan 25, 2023	BUY	$321.55 - $374.67 $257,240 - $299,736	800 New	800 $293 Million

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Afs Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Afs Financial Group, LLC with notifications on news.